LICARBAZEPINE
UNII XFX1A5KJ3V

Substance Identification & Data

This profile provides standardized clinical and technical data for Licarbazepine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XFX1A5KJ3V.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 29331-92-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

XFX1A5KJ3V

CAS Registry Number

29331-92-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LICARBAZEPINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C15H14N2O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

BMPDWHIDQYTSHX-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C81475

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

114709

Unique identification number in the NCBI database of chemical substances.

INN ID

7788

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

OC1Cc2ccccc2N(C(=O)N)c3c1cccc3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Licarbazepine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.